Alkaline Ceramidase 3 (ACER3) (C-Term) Peptide
| Name | Alkaline Ceramidase 3 (ACER3) |
| Synonyms | APHC, PHCA, FLJ11238, Phca, AV015045, 1110057L18Rik, 5430429L08Rik, phca, RGD1561254, MGC179542 |
| Binding Site |
C-Term |
 |
2 references available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN698572 |
| Quantity | 0.1 mg |
| Price | 49.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Immunogen | Synthetic peptide |
| Characteristics | Blocking peptide for ACER3 (C-term) antibody ABIN652900 |
| Specificity | The synthetic peptide sequence used to generate the antibody AP8953b was selected from the C-term region of human ACER3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Comments |
Background: ACER3 hydrolyzes only phytoceramide into phytosphingosine and free fatty acid. Does not have reverse activity. |
Application Details
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Restrictions | For Research Use only |
Publications
| Product |
Mao, Obeid: "Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate." in: Biochimica et biophysica acta, Vol. 1781, Issue 9, pp. 424-34, 2008 (PubMed).
Wheeler, Metter, Tanaka et al.: "Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging." in: PLoS genetics, Vol. 5, Issue 10, pp. e1000685, 2009 (PubMed). |
Sponsorship
2013 BioMed Central Research Awards
2013 BioMed Central Research Awards
